On November 12, 2019 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that the Company’s management will present a Company overview and update, as well as host investor meetings, at the following November conferences (Press release, Supernus, NOV 12, 2019, View Source [SID1234550966]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2019 Healthcare Conference
Date: November 19, 2019
Time: 1:50 p.m. ET
Place: Lotte New York Palace Hotel, New York

Jefferies 2019 London Healthcare Conference
Date: November 21, 2019
Time: 2:40 p.m. GMT / 9:40 a.m. ET
Place: Waldorf Hilton, London, UK
Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinators.

A live webcast of the presentations can be accessed by visiting ‘Events & Presentations’ in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of these webcasts will be available for 60 days on the Company’s website after the respective conferences.